BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T130000
DTEND;TZID=America/New_York:20200923T140000
DTSTAMP:20200920T191330Z
CREATED:20200920T191330Z
LAST-MODIFIED:20200920T191330Z
UID:47120-1600866000-1600869600@globalbiodefense.com
SUMMARY:The Effects of COVID-19 on Latin America and the Economic Outlook
DESCRIPTION:Please join the CSIS Americas Program and the CSIS Economics Program for a discussion on how the Covid-19 pandemic is affecting the outlook in Latin America. The ongoing surge in Covid-19 cases across the region raises questions about the timing of recovery\, adequacy of macroeconomic responses\, and the role of private and official sectors in responding to the unprecedented health and economic crises. This event will explore these issues\, as well as sector-specific outlooks in the wake of the pandemic\, and the outlook for sovereign and corporate debt. \nFeaturing a discussion with Geoffrey Okamoto\, Deputy First Managing Director\, International Monetary Fund. \nFollowed by a panel discussion: \n\nChris Campbell\, Chief Strategist\, Duff & Phelps Institute\nKevin Gallagher\, Professor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\nSamar Maziad\, Vice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\nModerated by Stephanie Segal\, Senior Fellow\, Economics Program\, CSIS \nThis event is made possible thanks to the generous support of the Duff & Phelps Institute. \nFEATURING\n\n\n\nGeoffrey Okamoto\nFirst Deputy Managing Director\, International Monetary Fund\n\n\n\n\n\nSamar Maziad\nVice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\n\n\n\n\nKevin Gallagher\nProfessor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\n\n\n\n\n\nChristopher Campbell\nChief Strategist\, Duff & Phelps Institute
URL:https://globalbiodefense.com/event/the-effects-of-covid-19-on-latin-america-and-the-economic-outlook/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200925T130000
DTEND;TZID=America/New_York:20200925T150000
DTSTAMP:20200922T225747Z
CREATED:20200922T225650Z
LAST-MODIFIED:20200922T225747Z
UID:47168-1601038800-1601046000@globalbiodefense.com
SUMMARY:COVID-19: Current State of the Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘COVID-19: Current State of the Pandemic” on 25 September 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the current pandemic hotspots in the US and globally\, including the epidemiology of the current wave of infections; discuss country-wide testing needs to mitigate and suppress COVID-19 infections; and review the evidence regarding possible re-infections of COVID-19\, and interpret the data behind the newest therapeutic guidelines for COVID-19. \nRegister here to attend the virtual event.
URL:https://globalbiodefense.com/event/covid-19-current-state-of-the-pandemic/
CATEGORIES:Conference,Continuing Education
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T090000
DTEND;TZID=America/New_York:20200929T163000
DTSTAMP:20200922T180748Z
CREATED:20200922T180416Z
LAST-MODIFIED:20200922T180748Z
UID:47143-1601370000-1601397000@globalbiodefense.com
SUMMARY:Pediatric Countermeasures: Children's National - NIAID Partnership Virtual Symposium
DESCRIPTION:A virtual symposium highlighting pediatric COVID-19 and MIS-C pandemic efforts undertaken by the NIAID-Children’s Hospital partnership will take place virtually on 29 September\, 2020. \nThis one day symposium bringing together investigators\, researchers\, and clinicians from the National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions\, to discuss the creation\, progress\, and evolution of this first-of-its-kind collaboration between the NIAID at the National Institutes of Health and Children’s National\, a pediatric academic medical center. \nThis year\, the event will highlight the current COVID-19 and MIS-C pandemic\, with a specific focus on the pediatric population. \nHighlighted speakers and topics include: \n\nOverview of SARS-CoV-2: Anthony S. Fauci\, MD (NIAID)\nRole of NCATS in the the SARS-CoV-2 Response: Christopher P. Austin\, MD (NCATS)\nHumoral Immune Response: Jeffrey I. Cohen\, MD (NIAID)\nCellular Response (T and NK Cells): Michael Keller\, MD (Children’s National)\nImmunopathogenesis of MIS-C: Sarah E. Henrickson\, MD\, PhD (CHOP)\nGenomic Factors in SARS-CoV-2: Helen Su\, MD\, PhD (NIAID)\nHealth Disparities and SARS-CoV-2: Akilah Jefferson Shah\, MD\, MSc (UAMS)\nClinical Spectrum of SARS-CoV-2\, Implication for Schools Reopening: Dan M. Cooper\, M.D. (UC Irvine)\nMIS-C and Post SARS-CoV-2 Monitoring in Children: Roberta DeBiasi\, MD\, MS (Children’s National)\nPost SARS-CoV-2 Monitoring in Adults: Michael C. Sneller\, MD (NIAID)\nOverview of Vaccine Candidates: Peter Hotez\, MD\, PhD (Baylor)\nCurrent State of Vaccine Clinical Trials: Julie Ledgerwood\, DO (NIAID)\nOngoing Therapeutic Trials and Treatment Guidelines: Cliff Lane\, M.D. (NIAID)\nSARS-CoV-2 What Comes Next – Societal/Economic Impact: Ezekiel Emanuel\, MD\, PhD (UPenn)\n\nIn 2017\, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic\, immunologic\, auto-inflammatory\, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership\, co-led by H. Clifford Lane\, M.D.\, Deputy Director for Clinical Research and Special Projects at NIAID\, and Mark Batshaw\, M.D.\, Executive Vice President and Chief Academic Officer at Children’s National\, holds the mission to generate and apply knowledge to promote the prevention\, diagnosis\, treatment\, and cure of these childhood diseases through its work together. \nFor each area\, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies\, diagnoses\, treatments\, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda\, Maryland. Together\, the two institutions provide comprehensive\, state-of-the-art pediatric clinical support\, infrastructure\, and research capacity. These resources protect the safety of children\, ensure that they receive the highest quality of care\, and offer them the opportunity to participate in cutting-edge clinical research. In addition\, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology\, allergic\, and infectious diseases. \nThe collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children’s National\, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University. \nRegister here. \n 
URL:https://globalbiodefense.com/event/pediatric-countermeasures-childrens-national-niaid-partnership-virtual-symposium/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/niaid-childrens-national-covid-19-research-countermeasures.jpg
LOCATION:
END:VEVENT
END:VCALENDAR